Leong, Hoyee

Potent ligand-independent estrogen receptor activation by 3,3'-diindolylmethane is mediated by cross talk between the protein kinase A and mitogen-activated protein kinase signaling pathways. [electronic resource] - Molecular endocrinology (Baltimore, Md.) Feb 2004 - 291-302 p. digital

Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.

0888-8809

10.1210/me.2003-0196 doi


Adenocarcinoma--drug therapy
Anticarcinogenic Agents--pharmacology
Cyclic AMP Response Element-Binding Protein
Cyclic AMP-Dependent Protein Kinases--antagonists & inhibitors
Cycloheximide--pharmacology
Endometrial Neoplasms--drug therapy
Enzyme Inhibitors--pharmacology
Estradiol--analogs & derivatives
Estrogen Antagonists--pharmacology
Estrogen Receptor alpha--drug effects
Female
Flavonoids--pharmacology
Fulvestrant
Humans
Indoles--pharmacology
Isoquinolines--pharmacology
Ligands
MAP Kinase Signaling System--drug effects
Phosphoprotein Phosphatases--antagonists & inhibitors
Phosphorylation--drug effects
Point Mutation
Sulfonamides--pharmacology
Transcription Factors--drug effects
Transcriptional Activation
Tumor Cells, Cultured